Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MHRA warning after drugs manufacturer recalls oral morphine solution

  • Comment
Healthcare professionals have been urged by the government’s drugs and medicines watchdog, the MHRA, to quarantine certain batches of an oral morphine solution.

The Medicines and Healthcare Products Regulatory Agency (MHRA) said drug manufacturer Boehringer/Ingelheim had recalled packs of 10mg/5ml Oramorph Oral Solution.

It had received complaints about deviation in taste and non-serious events and recalled affected batches of the drug, which are listed on the MHRA website.

All affected stock, which is used in hospitals and community pharmacies, should be quarantined and returned for credit, the MHRA said.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.